Fonte botanica

Momordin 2e is a cucurbitane triterpenoid compound, which is derived from natural plant sources, particularly within the gourd family, Cucurbitaceae. This product has garnered attention due to its bioactive properties, primarily identified in plants such as bitter melon (Momordica charantia).

Rebaudioside I is a steviol glycoside, which is a high-intensity sweetener derived from the leaves of the Stevia rebaudiana plant. As a natural compound, it is extracted and purified through a water or alcohol-based process from the plant’s leaves, which have been traditionally used for their sweetening properties.

Kaempferol 3-O-gentiobioside is a flavonoid glycoside, which is a naturally occurring compound commonly found in a variety of plant sources, including fruits, vegetables, and herbs. It is specifically derived from plants such as the Ginkgo biloba and other botanical sources that synthesize kaempferol derivatives as secondary metabolites.

Chonglou Saponin VII is a bioactive glycoside, which is derived from the rhizomes of traditional Chinese medicinal plants, often sourced from the species Paris polyphylla. As a steroidal saponin, its mechanism of action involves altering cellular activities by interacting with cell membranes and signaling pathways, leading to a range of pharmacological effects.

Quercetin 3-O-(4''-O-acetyl)-α-L-rhamnopyranoside is a specialized flavonoid glycoside, which is a derivative of the flavonoid quercetin. It is primarily sourced from various plant species known for their high flavonoid content. The compound is characterized by its unique glycosylation pattern, where an acetyl group is esterified to the 4'' position of the rhamnose moiety.

Rebaudioside G is a steviol glycoside, which is a natural sweetening compound derived from the leaves of the plant Stevia rebaudiana. This compound is one of several glycosides responsible for the sweet taste of stevia, which is native to South America and has been used for centuries for its sweetness.

Empagliflozin 6-O-β-D-glucuronide is a metabolite of the drug empagliflozin, which is a type of product known as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. This compound is derived from the in vivo metabolism of empagliflozin, originally sourced from synthetic pathways designed to enhance the management of type 2 diabetes mellitus. Its mode of action involves the facilitation of glucose excretion through the kidneys by inhibiting renal reabsorption of glucose, thus lowering blood glucose levels.

Jujuboside B is a bioactive compound, which is a triterpenoid saponin derived from the seeds of Ziziphus jujuba, known as the jujube plant. This compound is primarily found in the plant’s seeds and is extracted using various chromatography techniques. Jujuboside B exhibits its mode of action through modulation of neurotransmitter systems and antioxidative defense mechanisms, which contribute to its neuroprotective and anxiolytic effects. Additionally, it influences the GABAergic system, enhancing gamma-aminobutyric acid (GABA) neurotransmission.